Posts
Displaying 1 - 12 of 12 results
PCORI announces $150 million in funding for new health research
News Release
WASHINGTON, D.C. — The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling more than $150 million to support new patient-centered comparative clinical effectiveness research (CER)…
PCORI offers more than $500 million through new funding opportunities
News Release
WASHINGTON, D.C. — The Patient-Centered Outcomes Research Institute (PCORI) today began inviting proposals for new studies and projects through 10 funding opportunities. Five of these PCORI Funding Announcements (PFAs) are…
PCORI approves $80.5 million for health research using novel approaches to tackle social and clinical care factors that contribute to maternal health inequities
News Release
WASHINGTON, D.C. — The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $80.5 million to support four new, ambitious patient-centered comparative clinical effectiveness research (CER) studies focused on…
PCORI approves $225 million in funding for dozens of health research studies and related projects
News Release
WASHINGTON, D.C. — The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling $225 million, which include $207 million to support 20 new patient-centered comparative clinical…
PCORI approves $208 million for research on heart disease, chronic disease, palliative care and a range of conditions impacting people of all ages
News Release
WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $208 million to support 17 new comparative clinical effectiveness research (CER) studies, including four trials of…
PCORI approves $123 million for research on postpartum care, hypertension management, antibiotic prescribing and a range of conditions
News Release
WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $123 million to support 15 new research studies. These studies aim to fill evidence gaps, enhance…
PCORI approves $96 million for research on mental health, delirium, adolescent alcohol use among other conditions
News Release
WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $96 million to support 18 new research studies. These studies aim to fill evidence gaps and…
PCORI Board of Governors approves $71.5 million to fund new research studies on topics including maternal health, autism, and urinary incontinence
News Release
WASHINGTON, DC—The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today approved several slates of funding awards totaling about $71.5 million to support 12 new comparative clinical effectiveness research (CER)…
PCORI Researchers Are Answering Rapidly Emerging Questions about Telehealth
Blog
Telehealth—the use of digital information and communication technologies, such as computers and mobile devices, to access health care services remotely and manage health care—has grown in promise as technology has…
Can Some MS Patients Safely Stop Taking Medicines?
Blog
Multiple sclerosis is an often disabling neurological condition that affects about 400,000 people in the United States. People with MS can develop a wide variety of symptoms, including vision problems…
Can Patients with MS Safely Stop Taking Medicine as They Age? DISCOMS Trial's Results Indicate It's a Reasonable Option for Some
Research Study Highlight
Although new results from an ongoing PCORI-funded study into whether some patients with multiple sclerosis (MS) can safely stop taking certain kinds of medications as they age weren’t conclusive in…
TrACER Study: Changing Prescription Order Systems to Lower Risk of Febrile Neutropenia in Patients Starting Chemotherapy
Research Study Highlight
Some patients who receive chemotherapy develop a serious health problem called febrile neutropenia (FN), which involves having a fever and a low number of a type of white blood cells…